Public Companies

Ashland to explore Nutraceuticals sale amid reduced revenue

Ashland is planning to sell its Nutraceuticals business segment and invest in other core segments as its consolidates its portfolio.

CRISP developer secures $63M in new financing

MRA Group, the developer behind the Chestnut Run Innovation and Science Park (CRISP), has secured $63 million in financing for the project.

Artesian to raise nearly $35M in share sale

NEWARK – Artesian Resources, the water and wastewater utility company, expects to raise $34.8 million in a...

Prelude Therapeutics to raise $100M in share sale

Prelude Therapeutics announced Thursday that it’s selling millions of new shares to raise $100 million to support its drug pipeline research.
- Advertisement -

InterDigital inks licensing deals, raises share buybacks

WILMINGTON – InterDigital, the mobile and video technology research and development company, signed two technology licensing deals...

Chemours board member resigns over abortion, trans benefits

WILMINGTON – A longtime board of directors’ member for Chemours has resigned in dispute with leadership of...

Delaware employers begin severing Russian ties

More than two months after the war in Ukraine began, many of the multinational companies that have...

Incyte signs Japanese deal for eczema cream

WILMINGTON – Incyte announced recently that it has signed a deal with a Japanese dermatological product maker...
- Advertisement -

Navient quells activist threat with board seat

WILMINGTON – Navient, the publicly traded education loan servicing giant, has once again assuaged an activist investor,...

Prelude names president as it preps candidates

WILMINGTON – Prelude Therapeutics, the burgeoning cancer treatment research company, recently named its first president while it...

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact business in Delaware and beyond.

Current Issue

What's New

More Business News ...

Digital Partners